XML 39 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Xcede Technologies, Inc. Joint Venture (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Nov. 30, 2016
Nov. 30, 2016
Jun. 30, 2017
Jun. 30, 2017
Nov. 18, 2016
Debt Conversion, Original Debt, Amount       $ 5,500,000  
Debt Conversion, Converted Instrument, Amount       3,600,000  
Gain (Loss) on Extinguishment of Debt       1,900,000  
Noncontrolling Interest [Member]          
Debt Conversion, Original Debt, Amount   $ 3,100,000      
Debt Conversion, Converted Instrument, Shares Issued   3,055,551      
Gain (Loss) on Extinguishment of Debt       $ 300,000  
Xcede Technologies inc [Member]          
Debt Instrument, Interest Rate, Stated Percentage 5.00% 5.00%      
Committed Investment In Cash $ 1,200,000 $ 1,200,000      
Debt Conversion, Converted Instrument, Shares Issued   5,394,120      
Capital Stock Financing Discount Percentage 20.00% 20.00%      
Noncontrolling Interest, Ownership Percentage by Parent     61.00% 61.00% 59.00%
Noncontrolling Interest, Description       Noncontrolling interest represents the value of the Series A Preferred and common stock not owned by DBM plus 17% of cumulative losses of Xcede based on the 17% common stock ownership held by noncontrolling interests.  
Dynasil Biomedical [Member]          
Debt Conversion, Original Debt, Amount   $ 2,400,000      
Debt Conversion, Converted Instrument, Shares Issued   2,338,569      
Noncontrolling Interest, Ownership Percentage by Parent     83.00% 83.00%  
Gain (Loss) on Extinguishment of Debt       $ 1,600,000  
External Funding [Member] | Convertible Debt [Member]          
Debt Conversion, Original Debt, Amount   $ 5,200,000      
Secured Promissory Note [Member] | Xcede Technologies inc [Member]          
Debt Instrument, Interest Rate, Stated Percentage 2.00% 2.00%      
Debt Instrument, Maturity Date Dec. 31, 2025        
Notes Payable $ 1,500,000 $ 1,500,000      
Proceeds from Notes Payable   $ 500,000      
Expense Recognized In Long Term Contract     $ 33,000 $ 238,000  
Imputed Interest Rate       5.40%  
Series B Preferred Stock [Member]          
Preferred Stock, Liquidation Preference Per Share     $ 1.27 $ 1.27  
Preferred Stock, Liquidation Preference, Value     $ 500,000 $ 500,000  
Series A Preferred Stock [Member]          
Preferred Stock, Liquidation Preference Per Share     $ 1.016 $ 1.016  
Preferred Stock, Liquidation Preference, Value     $ 5,500,000 $ 5,500,000  
Series A Preferred Stock [Member] | Noncontrolling Shareholders [Member]          
Preferred Stock, Liquidation Preference, Value     3,100,000 3,100,000  
Series A Preferred Stock [Member] | Dynasil Biomedical [Member]          
Preferred Stock, Liquidation Preference, Value     $ 2,400,000 $ 2,400,000